A Randomized, Double-blind, Double-dummy, Parallel Group, Placebo Controlled Study Assessing The Efficacy Of Single Doses Of Pf-05089771 For The Treatment Of Postoperative Dental Pain Using Ibuprofen 400 Mg As Positive Control.
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2018
At a glance
- Drugs PF 5089771 (Primary) ; Ibuprofen
- Indications Dental pain; Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 01 Aug 2012 Actual end date Jun 2012 added as reported by ClinicalTrials.gov.
- 26 Jun 2012 Planned end date changed from 1 May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.